BC Extra | Jul 20, 2017
Preclinical News

Paper: GRK2 inhibitors could treat heart failure

In a paper published in the Journal of Medicinal Chemistry , researchers with Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) described a new class of small molecule G protein-coupled receptor kinase 2 ( GRK2 ; GPRK2) inhibitors that could...
BC Innovations | Feb 13, 2014
Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Prostate cancer G protein-coupled receptor kinase 3 (GRK3; ADRBK2) Mouse and human sample studies suggest inhibiting ADRBK2 could help suppress prostate...
BC Week In Review | Feb 11, 2008
Company News

Psynomics sales and marketing update

Psynomics launched its Psynome and Psynome2 tests for bipolar disorder. Psynome detects two mutations of the GRK3 gene that are associated with bipolar disorder. Psynome2 detects serotonin transporter response and predicts patient response to serotonin-based...
Items per page:
1 - 3 of 3